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Plasmodium falciparum var genes expressed in
children with severe malaria encode CIDRa1
domains
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Abstract
Most severe Plasmodium falciparum infections are experienced by
young children. Severe symptoms are precipitated by vascular
sequestration of parasites expressing a particular subset of the
polymorphic P. falciparum erythrocyte membrane protein 1
(PfEMP1) adhesion molecules. Parasites binding human endothelial
protein C receptor (EPCR) through the CIDRa1 domain of certain
PfEMP1 were recently associated with severe malaria in children.
However, it has remained unclear to which extend the EPCR-
binding CIDRa1 domains epitomize PfEMP1 expressed in severe
malaria. Here, we characterized the near full-length transcripts
dominating the var transcriptome in children with severe malaria
and found that the only common feature of the encoded PfEMP1
was CIDRa1 domains. Such genes were highly and dominantly
expressed in both children with severe malarial anaemia and cere-
bral malaria. These observations support the hypothesis that the
CIDRa1-EPCR interaction is key to the pathogenesis of severe
malaria and strengthen the rationale for pursuing a vaccine or
adjunctive treatment aiming at inhibiting or reducing the damag-
ing effects of this interaction.
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Introduction
The majority of children living in malaria endemic areas of Africa
suffer at least one attack of severe malaria during early childhood
(Goncalves et al, 2014). These malaria attacks caused by
Plasmodium falciparum parasites are life threatening, and it is esti-
mated that more than half a million children die each year (Murray
et al, 2014; Snow, 2014). Most of the millions of paediatric malaria
cases seeking treatment at primary health facilities are treated as
outpatients, but based on a clinical assessment, the physician
admits a small fraction of these children to hospital. Given adequate
treatment, most of these children survive, but even at the best facili-
ties, some die. On hospital admission, a few basic medical observa-
tions can identify children at risk of a fatal outcome. By far the
majority of deaths are found in those who have respiratory distress,
haemoglobin levels below 5 g/dl (severe anaemia) or are uncon-
scious (cerebral malaria) (Marsh et al, 1995). These broad clinical
categories do not constitute well-defined pathologies, and they often
overlap in the same patient. It is clear that severe malaria is associ-
ated with several different pathological processes such as proin-
flammatory and procoagulant activation of endothelial cells,
compromised blood–brain barrier, and vascular congestion caused
by infected erythrocytes (see recent review Wassmer et al, 2015). At
their late stages, P. falciparum infected erythrocytes sequester in
post-capillary venules and are not detected in peripheral blood. This
is thought to be the triggering phenomenon for many of the patho-
logical processes involved in severe malaria (MacPherson et al,
1985; Nguansangiam et al, 2007; Aguilar et al, 2014; Milner et al,
2015; Seydel et al, 2015; Wassmer et al, 2015). Immunity to the
severe forms of malaria is acquired early in life, and few children
suffer more than one or two life-threatening attacks (Goncalves
et al, 2014). A fundamental question is therefore whether parasites
causing severe malaria as opposed to uncomplicated disease share
common traits and whether different manifestations of severe
malaria can be linked to particular parasite features.
Plasmodium falciparum erythrocyte membrane protein 1
(PfEMP1) are parasite-derived proteins, which anchor infected
erythrocytes to receptors on the vascular lining, and by this process
of sequestration the parasites avoid splenic clearance and death
(Hviid & Jensen, 2015). Each P. falciparum genome contains
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~60 var genes that encode different PfEMP1 molecules (Baruch et al,
1995; Smith et al, 1995; Su et al, 1995). Var gene regulation
ensures that only one PfEMP1 variant is expressed on the surface
of each infected erythrocyte (IE) (Scherf et al, 1998); however,
several PfEMP1 variants are expressed by the many millions IEs
present in an infected individual. Accumulated evidence converge
towards the hypothesis that severe malaria is caused by parasites
expressing a distinct subset of PfEMP1 and that antibodies to these
PfEMP1 types are the mediators of an early acquired immunity
protecting children from severe malaria attacks (Bull et al, 1998;
Nielsen et al, 2002; Cham et al, 2009, 2010; Hviid & Jensen, 2015;
Turner et al, 2015). Under the dual evolutionary pressure to retain
host receptor interaction capacity while diversifying to escape
immune recognition, var genes have acquired extreme sequence
diversity, but within a highly ordered genetic organization and
composition of encoded domains that correlate with host receptor
binding phenotypes (Lavstsen et al, 2003; Kraemer & Smith, 2006;
Rask et al, 2010; Sander et al, 2014). Thus, binding to endothelial
protein C receptor (EPCR) is restricted to PfEMP1 molecules
belonging to a subgroup of subtelomeric group A var genes and a
distinct group of subtelomeric group B var genes encoding domain
cassette (DC) 8 (Turner et al, 2013). Other subtelomeric group B
and centromeric group C var genes encode PfEMP1 molecules
predicted to bind CD36 (Robinson et al, 2003). We have previ-
ously shown that parasite expression of EPCR-binding PfEMP1 is
associated with severe malaria syndromes in hospitalized African
children (Lavstsen et al, 2012; Bertin et al, 2013; Turner et al,
2013). In these studies, var transcript levels were quantified by
real-time PCR using primers specific for gene loci unique to speci-
fic PfEMP1 domain types. This approach allowed analysis of
disease association of domain types targeted by the employed
primers, which due to the sequence diversity of var genes could
not cover all domain types. Consequently, full annotation of the
var genes expressed in children with severe malaria has not been
achieved, and it has remained uncertain if domain types or
domain compositions not targeted by the primers employed in the
previous studies show association to severe malaria in children.
In the present paper, we have used an alternative approach
(Fig 1), which allowed identification and near full-length annotation
of the most prominently expressed var genes in individual patients.
The results show that the only common characteristic of var tran-
scripts in severe paediatric malaria patients was coding for domains
predicted to bind EPCR.
Results
Annotation of var transcripts in individual patients
Var transcript profiles were characterized in parasites from 36
children admitted to hospital and diagnosed with severe malaria.
Twenty-one patients had severe anaemia without severe cerebral
impairment (Blantyre coma score > 2), nine had cerebral malaria
without severe anaemia (Hb > 5 g/dl), four patients had overlap-
ping syndromes, and two were hyperparasitemic with no other
severe complication (Table 1). In addition, var transcripts were
studied in samples from eight hospitalized children diagnosed with
uncomplicated P. falciparum infections (Table 1). Analysis of var
transcript distributions by DBLa-tag sequencing showed that the six
most frequent var transcripts accounted for on average 74% of a
patient’s var transcript profile, with the 7th most frequent transcript
accounting for < 1% on average. Full-length sequence information
of the six most frequent transcripts in each patient was therefore
pursued. Annotation of Duffy Binding-Like (DBL) and Cysteine-rich
Inter Domain Region (CIDR) domains encoded by the var transcripts
identified in the 44 individuals is shown in Appendix Fig S1.
Comparison of var transcript based on classification of
N-terminal domains
All PfEMP1s, apart from VAR2CSA and VAR3, have an N-terminal
DBLa-CIDR tandem domain arrangement (Fig 1, upper panel),
where the CIDR domains divide into three sequence classes, for
which the human receptor binding phenotype can be predicted.
CIDRa1-carrying PfEMP1s are predicted to bind EPCR (Lau et al,
2015), and CIDRa2-6-carrying PfEMP1s are predicted to bind CD36
(Robinson et al, 2003), whereas the binding phenotypes are
unknown for CIDRb, c and d domains. For this reason, the distribu-
tion of the top six var transcripts was first analysed in relation to the
encoded N-terminal CIDR type. The proportion of var transcripts
encoding CIDRa1 predicted to bind EPCR domains was higher in
children with severe malaria than in children with uncomplicated
disease (median proportion 54.1 vs. 7.4%, P = 0.005, Table 2)
(Fig 2). The opposite was seen in the proportion of transcripts
encoding predicted CD36-binding CIDRa2-6 domains (median 17.0
vs. 43.7%, P = 0.04). In children with severe malaria, EPCR-binding
PfEMP1 was transcribed by both group B (DC8, carrying CIDRa1.
[1/8] domains) and group A (carrying CIDRa1.[4–7] domains) EPCR-
binding PfEMP1 (median transcript proportions 15.5 and 16.7%, for
groups B and A, respectively). The median proportion of transcripts
encoding N-terminal CIDRb, CIDRc or CIDRd domains was zero in
children with both severe and uncomplicated disease. Because the
DBLa and N-terminal CIDR domains are found in tandem, the CIDR
domain type can to some extend be predicted by the DBLa-tag
sequence (see Materials and Methods). This allowed identification of
putative EPCR-binding variants among the highly transcribed var
genes where full-length sequence information could not be obtained.
When these transcripts were added to the proportion of CIDRa1
encoding transcripts, the median proportion of EPCR-binding
PfEMP1 transcripts in patients with severe and uncomplicated
malaria was 62.3% and 7.9%, respectively (P = 0.002) (Table 2).
Comparison of transcript proportions in patients with severe
anaemia and cerebral malaria showed that patients with severe
anaemia had a higher proportion of group B type DC8 transcripts
(i.e. encoding CIDRa1.[1/8] domains) than patients with cerebral
malaria (median levels 16.3 and 0%, respectively P = 0.16) (Table 2
and Fig 2). The opposite trend was observed for group A transcripts
encoding proteins predicted to bind EPCR (i.e. encoding CIDRa1.[4–
7]) (11.5 and 39.6% for severe anaemia and cerebral malaria,
respectively, P = 0.06). This difference was due to a statistically
significant higher proportion of transcripts encoding CIDRa1.4 in
patients with cerebral malaria (0 and 25.3% for severe anaemia and
cerebral malaria, respectively, P = 0.02). The median ratio between
group A and group B CIDRa1 transcript proportions was 1.0 in
severe anaemia patients and 26.3 in patients with cerebral malaria
(P = 0.04).
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When the var transcript patterns were analysed according to the
DBLa domain annotation, the results resembled those from the analy-
sis based on N-terminal CIDR annotation (Appendix Table S1).
Proportions of transcripts encoding DBLa0-containing PfEMP1s
predicted to bind CD36 were higher in patients with uncomplicated
malaria than in those with severe malaria (43.7 vs. 20.8% for
uncomplicated and severe malaria, respectively, P = 0.05), and the
opposite trend was observed for transcripts encoding DBLa
(DBLa1.[1/2/4/7] and DBLa2) linked to EPCR-binding CIDR
domains (9.3 and 65.0% for uncomplicated and severe malaria,
Table 1. Clinical characteristics of patients.
Patients characteristics
Uncomplicated
malariaa (n = 8)
Severe malariab
(n = 36)
Severe anaemiab
(n = 21)
Cerebral
malariab (n = 9)
Age (mean  SD, years) 2.1  1.0 2.3  1.3 1.8  0.9 3.1  1.8
Minimum/maximum 0.5–3.2 0.15–6.2 0.15–3.4 0.6–6.2
Males (%) 37.5 41.7 47.6 33.3
Parasitaemia (median, p/ll) 26,355 65,013 30,275 61,285
IQR 10,745–49,385 16,870–139,615 12,543–113,418 38,693–171,483
Temperature (median, °C) 38.5 38.0 37.6 37.7
IQR 37.3–39.6 37.1–39.0 37.4–38.7 36.6–39.4
Haemoglobin (mean  SD, g/dl) 6.9  1.8 4.8  1.8 3.9  0.8 7.7  1.6
Minimum/maximum 5.1–9.9 1.7–10.5 1.7–4.9 5.8–10.5
Coma score (mean) 3.9 3.6 4.8 1.3
IQR 3–5 2–5 5–5 0–2
Minimum/maximum 2–5 0–5 3–5 0–2
Lactate (mean  SD, mM) 5.1  2.3 6.1  3.3 6.0  3.2 6.6  5.1
Minimum/maximum 2.4–9.0 1.6–17.2 2.0–15.2 1.6–17.2
Glucose (mean  SD, mM) 4.1  1.7 5.3  2.2 5.0  1.5 6.6  2.8
Minimum/maximum 1.1–5.7 1.1–13.4 2.2–8.9 4.0–13.4
Mortality (%) 25.0 5.6 4.8 11.1
IQR, inter-quartile range.
aPatients admitted without fulfilling the criteria for classification as severe malaria cases. Two were septicemic and died.
bSevere malaria: Hb < 5 g/dl or Blantyre coma score ≤ 2 or ≥ 200,000 parasites/ll. Severe anaemia: Hb < 5 g/dl and Blantyre coma score > 2. Cerebral malaria:
Hb ≥ 5 g/dl, Blantyre coma score ≤ 2 and absence of other clinical findings explaining the impaired consciousness. Four patients were diagnosed with both SA
and CM, and two were hyperparasitemic with no other severe complications.
Table 2. Proportions (%) of var transcripts by encoded N-terminal CIDR domain type.
Domain subtypes
Uncomplicated
malaria (n = 8)
Severe malaria
(n = 36)
Pa
Severe anaemia
(n = 21)
Cerebral malaria
(n = 9)
PaMedian (%) [IQR] Median (%) [IQR] Median (%) [IQR] Median (%) [IQR]
CIDRa1 7.4 [0–19.3] 54.1 [19.4–72.3] 0.005 63.5 [16.3–70.0] 53.1 [37.6–67.6] 0.60
CIDRa1 or CIDRa1-predictionb 7.9 [0–21.9] 62.3 [26.5–74.7] 0.002 65.7 [27.8–74.7] 64.1 [37.6–67.6] 0.91
CIDRa1.[1/8] 0 [0–3.6] 15.5 [0–31.1] 0.03 16.3 [0–42.2] 0 [0–19.1] 0.16
CIDRa1.[4–7] 3.8 [0–9.4] 16.7 [0–47.6] 0.08 11.5 [0–29.4] 39.6 [14.0–67.6] 0.06
CIDRa1.4 0 [0–0] 0 [0–20.0] 0.05 0 [0–0] 25.3 [0–39.9] 0.02
CIDRa1.[4–7]: CIDRa1.[1/8] ratioc 1.0 [0.65–8.9] 1.0 [0.34–9.1] 0.64 1.0 [0.19–3.2] 26.3 [0.69–66.6] 0.04
CIDRa2-6 43.7 [21.9–84.7] 17.0 [0–33.4] 0.04 14.1 [0–32.1] 13.0 [4.0–25.0] 0.91
CIDR1b 0 [0–0] 0 [0–0] 0.53 0 [0–0] 0 [0–0] 0.35
CIDR1c 0 [0–0] 0 [0–0] 0.98 0 [0–0] 0 [0–7.6] 0.17
CIDR1d 0 [0–29.8] 0 [0–0] 0.02 0 [0–0] 0 [0–0] 0.51
aP-values were calculated using Wilcoxon rank-sum test.
bTranscripts annotated with a CIDRa1 domain or predicted by the DBLa-tag sequence to encode a CIDRa1 domain.
cThe patient-wise ratio between the level of transcripts encoding group A type CIDRa1 domains (CIDRa1.[4–7]) and group B type CIDRa1 domains (CIDRa1.[1/8])
was calculated as follows: (∑CIDRa1.[4–7] + 0.01) : (∑CIDRa1.[1/8] + 0.01).
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respectively, P = 0.005). Proportions of transcripts encoding
DBLa1.5, DBLa1.6 or DBLa1.8 domains linked to N-terminal CIDRb,
CIDRc or CIDRd domains were low and not associated with severe
clinical status.
Transcript patterns in individual patients
The N-terminal CIDR types encoded in individual patients are
shown in Fig 3. In most cerebral malaria patients, transcripts encod-
ing EPCR-binding PfEMP1 were found in high proportions. In some
of these patients, the profiles were dominated by group A transcripts
encoding EPCR-binding PfEMP1 (e.g. patients 1918, 1914 and 1950),
and in some patients, DC8 transcripts dominated (e.g. patients 1919
and 2014). In two cerebral malaria patients, the transcript profile
was dominated by transcripts encoding proteins predicted to bind
CD36 (patients 1996, 1995). In some patients with severe anaemia
transcripts mainly encoded DC8 PfEMP1 (e.g. patients 1965, 2120,
1920, 2142 and 2268), but in other severe anaemia patients, tran-
scripts for EPCR-binding group A PfEMP1 dominated (e.g. patients
1939 and 2132). In a few of these patients, the dominating var tran-
scripts were predicted to bind CD36 (patients 1931, 2021 and 1734).
In most of the eight patients with uncomplicated malaria, the profile
was dominated by transcripts encoding proteins predicted not to
bind EPCR.
Transcript patterns based on classification of other
PfEMP1 domains
In addition to the N-terminal domains, group A and DC8 PfEMP1
can contain DBLb, DBLc, a DBLd-CIDR structure as well as DBLf
and DBLe domains. Some DBLb domain types have been linked to
intercellular adhesion molecule 1 (ICAM1) binding (DBLb5 of group
MiSeq
sequencing
Peripheral blood sample 454 FLX 
sequencing
Count 
reads from 
each tag
var expression profile
Genomic DNA 
extraction
Design DBLα
specific primers
Assemble genes
DBLα tag PCR
var transcripts
Long range PCR
var genes of interest
RNA 
extraction
cDNA
synthesis
Annotation
var gene / PfEMP1
BLAST 
domains
Figure 1. Var gene/PfEMP1 structure and expression analysis work flow.
Var gene structure (upper panel). Var genes consist of two exons, with exon 1 encoding the ectodomain exposed on the infected erythrocyte surface and interacting with human
receptors. Exon 1 encodes the N-terminal segment (NTS), a variable number of DBL and CIDR domains and the transmembrane region (TM). Exon 2 encodes the intra-
erythrocytic part of the protein, the more conserved acidic terminal segment (ATS). Var expression analysis work flow (lower panel). Plasmodium falciparum DNA and RNA was
extracted from patient samples. Using cDNA from total RNA, var transcript profiles were generated by counting sequencing reads of PCR-amplified DBLa sequences using
primers targeting semi-conserved loci flanking the DBLa-tag sequence. Based on this sequence information, single var gene-specific 50 primers were designed for each of the
most abundant var transcripts detected by the DBLa-tag PCR and paired with a 30 primer targeting a conserved locus in exon 2 to perform a long-range PCR on genomic DNA.
The resulting near full-length var gene fragments were sequenced, assembled and annotated.
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B and DBLb3 of group A PfEMP1 (Smith et al, 2000; Bengtsson
et al, 2013). The binding specificity of the remaining C-terminal
domains is uncertain, but several of these domains form domain
cassettes (Rask et al, 2010). None of these domain types alone, in
domain cassettes or domain count alone, were associated with
severe malaria or severe malaria syndrome (Appendix Table S2 and
Fig EV1), although the common four domain groups B and C
PfEMP1 as well as PfEMP1 with DBLf or DBLe domains were associ-
ated with uncomplicated malaria in agreement with previous obser-
vations made by quantitative PCR analysis of var transcript analysis
(Lavstsen et al, 2012).
In order to investigate whether a particular subset of EPCR-
binding PfEMP1 were associated with severe malaria or severe
malaria syndrome, the domain composition of expressed EPCR-
binding PfEMP1 was compared to the occurrence of these domains
and domain compositions within EPCR-binding PfEMP1 encoded by
the average parasite genome (Rask et al, 2010). No separate domain
composition within EPCR-binding PfEMP1 was found to be associ-
ated with expression in the patients.
Discussion
The epidemiology of severe malaria in areas of high transmission,
serological typing of parasites from children with severe disease and
antibody profiling in children surviving their first malaria attacks
(Bull et al, 1998; Nielsen et al, 2002) suggest that severe paediatric
malaria is precipitated by P. falciparum expressing a distinct set of
PfEMP1 molecules on the surface of infected erythrocytes (Smith
et al, 2013). This group of molecules is predicted to share features
that make the parasites expressing them particularly dangerous to
the host, most likely by conveying a particular host receptor binding
phenotype. Different PfEMP1 molecules have been shown to bind
different endothelial receptors, and mediate formation of rosettes
with uninfected erythrocytes (see review Hviid & Jensen, 2015).
However, in vitro phenotypic profiling of parasites isolated from
patients has failed to identify a binding phenotype consistently asso-
ciated with severe disease outcome. It has also proved difficult to
associate specific PfEMP1 sequence types to severe malaria
syndromes, mainly due to large size and sequence diversity of var
genes. Most studies have relied on characterizing expressed DBLa-
tags (Kirchgatter & Portillo Hdel, 2002; Kyriacou et al, 2006;
Normark et al, 2007; Falk et al, 2009; Warimwe et al, 2009) and
have highlighted the importance of group A var genes. These studies
were limited to inform only on the DBLa domain and could not
distinguish between group A genes encoding CIDRa1 or other
N-terminal CIDR domains, nor could they reliably discriminate
between CD36-binding group B-C genes and EPCR-binding group B
(DC8) genes. Other studies have employed quantitative PCR target-
ing a broader range of var gene features (Rottmann et al, 2006;
Lavstsen et al, 2012; Bertin et al, 2013). These studies associated
expression of DC8 var genes with children suffering from severe
malaria symptoms and emphasized the particular importance of
group A var genes encoding the CIDRa1 domain, including the
DC13 variants. Later studies showed that DC8 PfEMP1 and a subset
of group A PfEMP1 molecules mediate binding to EPCR through
their N-terminal CIDRa1 domain (Turner et al, 2013; Lau et al,
2015), implicating EPCR-binding as an important feature of parasites
causing severe malaria. However, a complete description of the
domain composition of the PfEMP1 molecules expressed by para-
sites causing severe malaria was missing and the relative impor-
tance of different domain types including those predicted not to
bind EPCR was left unanswered.
In this study, we extracted the near full-length PfEMP1 ectodo-
main sequence of the most prominently expressed var genes in 44
patients. This provides the most comprehensive characterization of
var transcripts in patients with severe paediatric malaria to date.
The DBL and CIDR domains in PfEMP1 have an impressive but
not unlimited capability to tolerate sequence mutation. DBL and
CIDR domain share core structural features (Lau et al, 2015) and
are readily divided into relatively few distinct sequence subtypes
(DBLa-f and CIDRa-d). Different groups of PfEMP1 molecules are
characterized by having an ordered domain composition, and a
tightly controlled recombination mechanism is acting to keep
domain types and domain order in place (Lavstsen et al, 2003;
Kraemer & Smith, 2006; Rask et al, 2010; Sander et al, 2014). In
agreement with this, PfEMP1 receptor specificity appears to be
linked to particular DBL and CIDR subtypes. The most striking
example of this is the binding of PfEMP1 to EPCR by CIDRa1
domains, CD36 by CIDRa2-6 domains, and to neither (but probably
yet unidentified receptors) by CIDRb/c/d domains.
In each patient, several different var transcripts were detected,
but the majority of transcripts arose from less than a handful of
genes. In children with severe malaria, the most frequent tran-
scripts encoded EPCR-binding CIDRa1 domains, these group A or
group B (DC8) var genes dominated the var gene transcriptome in
most patients with severe disease, and they were far more domi-
nant than expected from the distribution of these var gene
subtypes in the parasite genome. Conversely, transcripts encoding
PfEMP1 predicted to bind CD36, which are also found in highest
number in the parasite genome, dominated in the patients
with uncomplicated malaria. Group A var transcripts encoding
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Figure 2. Distribution of var transcripts and genes by encoded
N-terminal CIDR domain type within patient groups and the average
Plasmodium falciparum genome.
Red: CIDRa1.[1/8] (DC8, binds EPCR), orange: CIDRa1.[4–7] (group A, binds EPCR),
green: CIDRa2-6 (group B/C, binds CD36), blue: CIDRb/c/d (group A, unknown
bindingphenotype), grey:var1,white: CIDR typenot identified. Severemalaria (SM),
cerebral malaria (CM), severe anaemia (SA) and uncomplicated malaria (UM).
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N-terminal CIDRb/c/d domains were not prominent in any patient
group.
In agreement with a recent study (Abdi et al, 2015), there was a
tendency that group A genes predicted to bind EPCR were more
prominent in patients with cerebral malaria, whereas DC8 (group B)
genes were more prominent in patients with severe anaemia
(Table 2). However, this association was by no means absolute, as
some cerebral malaria patients had dominant DC8 transcription and
some severe anaemia patients were dominated by transcripts encod-
ing group A EPCR-binding PfEMP1s. Also, all of the six subtypes of
EPCR-binding CIDRa1 (1.1 and 1.4–1.8) were found highly
expressed in at least some patients with severe malaria. Thus, it is
likely that future vaccines aiming to protect children against severe
malaria by induction of antibodies inhibiting the CIDRa1-EPCR
interaction should target all EPCR-binding CIDRa1 subgroups.
In a few patients with severe malaria (~11%), < 10% of the var
transcript profile could be ascribed transcripts identified to encode
EPCR-binding PfEMP1, indicating that severe malaria in some cases
could be precipitated in the absence of EPCR-binding parasites.
However, it is also possible that severe symptoms in these patients
were precipitated by other pathologies than malaria. Studies from
Malawi have shown that about 25% of malaria patients classified as
having cerebral malaria based on clinical findings, after autopsy
was concluded to have died from other causes (Taylor et al, 2004;
Milner et al, 2015). The finding that some of the patients with
uncomplicated malaria showed high proportions of transcripts
encoding EPCR-binding PfEMP1 was expected, as these children
might well have developed severe symptoms had the infection been
allowed to progress without administration of antimalarial drugs.
ICAM1 binding has been described as an important binding
phenotype in severe malaria (Berendt et al, 1989; Newbold et al,
1997; Ochola et al, 2011; Turner et al, 2015). ICAM1 binding has
been mapped to DBLb3 and DBLb5 domains (Smith et al, 2000;
Howell et al, 2008; Brown et al, 2013; Gullingsrud et al, 2013)
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Figure 3. Distribution of var transcripts by their encoded N-terminal CIDR domain type within individual patients.
Patient numbers and diagnoses cerebral malaria (CM), severe anaemia (SA), hyperparasitemia (HYPER) and uncomplicatedmalaria (UM). Patients who died are indicated with
(†). Red: CIDRa1.[1/8] or DBLa2 prediction (DC8, binds EPCR), orange: CIDRa1.[4–7] (group A, binds EPCR), green: CIDRa2-6 (group B/C, binds CD36), blue: CIDRb/c/d (group A,
unknown binding phenotype), grey: var1, white: CIDR type not identified.
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predominantly found in group A and B PfEMP1, respectively. Genes
encoding potential ICAM1-binding group B PfEMP1 were expressed
in some patients, but at a low level and with no association to
disease severity or syndrome (Appendix Table S2 and Fig EV1).
Expression of group A genes encoding DBLb3 domains was found
more frequently, and more often than expected from genomic preva-
lence, but with no clear association to severe disease or severe
disease syndrome. However, the current study included relatively
few patients and was not powered to detect traits that contribute to
disease severity in a minor part of the patients with severe malaria.
The molecular basis for the DBLb-ICAM1 interaction is poorly
understood, making prediction of ICAM1-binding domains uncer-
tain. Nevertheless, our results suggest that severe malaria can be
precipitated in the absence of ICAM1 binding (e.g. by EPCR-binding
DC8 PfEMP1 previously found not to bind ICAM1; Avril et al, 2012;
Claessens et al, 2012) and that ICAM1 binding in absence of EPCR
binding (via group B-C PfEMP1 not binding EPCR; Janes et al, 2011)
is not an important determinant of severe malaria. However, the
observation that EPCR-binding group A PfEMP1 was more frequent
in cerebral malaria patients compared to those with severe malaria
anaemia could reflect a dual EPCR and ICAM1 binding capability of
some of these PfEMP1 variants (Bengtsson et al, 2013). Further
elucidation of the molecular determinants of PfEMP1–ICAM1
interaction and ability to predict ICAM1-binding from the amino
acid sequence is required to assess the role that group A PfEMP1
binding both ICAM1 and EPCR play in the pathogenesis of cerebral
malaria.
Rosetting, the binding between an infected erythrocyte and
several uninfected erythrocytes, has been associated with parasites
isolated from severe malaria patients (Carlson et al, 1990; Rowe
et al, 1995; Heddini et al, 2001). This binding phenomenon may
be mediated by DBLa1.[5/6/8] domains (Rowe et al, 1997; Chen
et al, 1998; Angeletti et al, 2015) found in context with CIDRb,
CIDRc and CIDRd domains (Juillerat et al, 2011; Ghumra et al,
2012). Such genes were not prominently expressed in the patients
with severe malaria (e.g. Fig 2). Instead, transcripts in severe
malaria patients were most often encoding DBLa types found in
CIDRa1 containing PfEMP1 binding EPCR. However, a clinical
importance of rosetting remains unclear, as the phenotype cannot
be predicted from the PfEMP1 amino acid sequence (Horata et al,
2009) and has also been associated with both RIFIN (Goel et al,
2015) and STEVOR proteins (Niang et al, 2014). PECAM1 binding
(Treutiger et al, 1997) has been associated with PfEMP1 containing
DC5 (Berger et al, 2013), but var transcripts encoding DC5 PfEMP1
were not found in high abundance in the studied children. Binding
to IgM (Semblat et al, 2006, 2015; Stevenson et al, 2015a) and
alpha-2-macroglobulin (Stevenson et al, 2015b) has been mapped
to C-terminal PfEMP1 domains, DBLe and/or DBLf, which exhib-
ited higher transcript proportions in children with uncomplicated
malaria (Fig EV1).
The transcript levels of var2csa and var3 cannot be assessed by
the DBLa-tag method used here. These two var genes are highly
conserved and easily investigated by quantitative PCR. Neither
var2csa nor var3 was found highly expressed in children with paedi-
atric malaria by quantitative PCR analysis of samples from the same
patient population investigated in this study (Lavstsen et al, 2012).
In conclusion, the only PfEMP1 domain consistently associated
with severe paediatric malaria, regardless of qualifying syndrome,
was CIDRa1 predicted to mediate EPCR binding. This raises the
question whether the interaction with EPCR provokes all the various
pathological processes initiated by parasite sequestration. EPCR acti-
vation of protein C plays an essential role in the regulation of coagu-
lation, vascular inflammation and endothelial permeability
(Bouwens et al, 2015). PfEMP1 binding to EPCR inhibits protein C
conversion (Gillrie et al, 2015; Petersen et al, 2015; Sampath et al,
2015), and thus, parasite sequestration through EPCR engagement
could directly influence pathogenic processes leading to unfavour-
able inflammation and coagulation events (Moxon et al, 2013) as
well as leakage through the blood–brain barrier and brain swelling
(Seydel et al, 2015). While the presence of sequestered parasites in
the brain is believed to be key to the organ specific pathology in
cerebral malaria, it is unclear whether sequestration in the bone
marrow promotes development of anaemia. However, sequestration
of blood stage parasites and deposition of haemozoin is a common
finding in bone marrow aspirates from anaemic children living in
malaria endemic areas (Aguilar et al, 2014). Future studies must
establish if the PfEMP1 binding to EPCR in itself contributes to
development of anaemia.
PfEMP1 with CIDRa1 domains is large multidomain molecules,
and it is possible that other domains potentiate the parasite cytoad-
hesion and could contribute to pathogenesis systemically or in
specific organs. It is also possible that variations of host genetic or
epigenetic factors or co-infections (Hochman et al, 2015) exacerbate
or direct disease outcome.
There is little doubt that severe malaria is a multifaceted disease
governed by several host and parasite factors. However, the data
presented here strongly indicate that the interaction between
CIDRa1 and EPCR is the main and consistent driver for development
of severe malaria.
Materials and Methods
Patients
As part of an effort to monitor malaria in Korogwe District, north-
eastern Tanzania, children under the age of five admitted at
District Hospital (KDH) from August 2006 to July 2009 with the
intention to treat for malaria were enrolled for this study after
having received informed consent from the parents or legally
acceptable representative. Experiments conformed to the principles
set out in the WMA Declaration of Helsinki and the Department of
Health and Human Services Belmont Report. This study was
granted ethical clearance and approval by the Tanzania National
Health Research Committee with reference NIMR/HQ/R.8a/Vol.IX/
559. Previously, patient samples were randomly selected from a
database analysed for var abundances using quantitative PCR
(Lavstsen et al, 2012). Those of these samples where additional
Trizol preserved RNA were available were included in the
present study. For the analysis of var transcripts, patients were
characterized as having severe malaria if presenting with respira-
tory distress, Blantyre score ≤ 2, severe anaemia (< 5 g/dl) or
hyperparasitemia (≥ 200,000 parasites/ll) and absence of any
other disease explanatory clinical finding. Patients without any of
these syndromes or with confounding clinical conditions were
classified as uncomplicated malaria cases.
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Var transcript analysis strategy
First, the relative abundance of var transcripts in each patient was
determined by cDNA DBLa-tag PCR amplification, sequencing and
counting of reads (Fig 1). Two identical DBLa-tags are rarely
observed in the parasite population (Barry et al, 2007), and the
DBLa-tag PCR primers are designed to target all var genes, with the
exception of the conserved var2csa and var3 genes (Lavstsen et al,
2012). On average, the six most frequent DBLa-tags accounted for
74% (min–max; 38–100%) of each patient’s var transcript profile,
with an average individual proportion of 13%. To acquire compre-
hensive insight into the PfEMP1 types most prominently expressed
in severe malaria patients, a specific 50 primer was designed for each
of the DBLa-tags of the six most abundant var transcripts of each
patient and paired with a universal 30 primer targeting a semi-
conserved locus in exon 2 (Fig 1). These primers were then used to
PCR amplify var gene fragments, encoding the near-complete
PfEMP1 ectodomain, which in turn were sequenced and annotated.
Var gene assemblies and transcript abundances were validated
using gene-specific primers using conventional and quantitative
PCR on each patient sample. A list of assembled and annotated tran-
scripts is shown in Appendix Fig S1.
For some genes, it was not possible to amplify the full-length
gene or to assemble the full sequence. For these domain un-
annotated genes, the DBLa-tag sequence information was used to
assign the transcript to a var group as follows: because the DBLa
and CIDR domains always are found in tandem, the CIDR type and
its binding phenotype can be predicted from the sequence of the last
subdomain of DBLa, that is subdomain 3 (S3) (Lavstsen et al,
2012), and to a lesser extent also from DBLa subdomain 2 (S2)
captured by the DBLa-tag. DBLa-tags can differentiate group A
(DBLa1-tags) from group B and C (DBLa0-tags) var genes, but can
only to some extend predict binding phenotypes of the encoded
PfEMP1. While CD36 binding is exclusively found in groups B and C
encoded PfEMP1, EPCR-binding PfEMP1 variants are encoded by
approximately half of all group A genes as well as by a small subset
(~6%) of B genes, encoding DC8. Using the added information from
annotated genes in this study along with all other known full-length
PfEMP1 sequences, analysis of a sequence distance tree built on the
DBLa-tag sequences showed several subclusters mainly comprised of,
and including most of DBLa2-tags. We used these clusters to identify
likely DC8 var transcripts among the un-annotated var transcripts.
RNA, cDNA and gDNA
Venous blood was drawn into citrate buffer at the time of patient
admission. Total RNA was extracted following manufacturer’s
instructions from 50 to 200 ll packed RBCs lysed in 1,300 ll Trizol
RNA preserving reagent (Invitrogen) stored at 80°C. Prior to cDNA
synthesis, RNA was treated with DNase I (Sigma) to eliminate any
contaminating genomic DNA. The sample was considered DNA free
when fluorescence was still baseline after 30 cycles of quantitative
PCR (qPCR) with seryl-tRNA synthetase primers. cDNA was synthe-
sized by reverse transcription using SuperScript II and random
hexamers (Invitrogen) at 25°C for 10 min, 42°C for 50 min and 70°C
for 15 min. Genomic DNA was extracted from patient buffy coats by
the automated Maxwell16 system (Promega) or manually by the
NucleoSpin Blood kit (Macherey–Nagel). Although mainly patient
DNA, sufficient amounts of P. falciparum DNA was extracted for
the PCR amplification of relevant genes.
DBLa-tag PCR
The DBLa-tag primers (Lavstsen et al, 2012) were synthesized as
fusion primers, which allows amplicons to fit directly into the Roche
GS FLX Titanium emulsion PCR (Lib-L) sequencing preparation
pipeline (http://www.tgac.ac.uk/uploads/Amplicon%20Fusion%20
Primer%20Design%20Guidelines%20TGAC.pdf; http://454.com/down
loads/my454/applications-info/APP001-2009-Lib-L-Unidirectional-
Amplicons.pdf). The forward fusion primer had the following
composition: 50-sequencing adapter sequence A—barcode sequence
—template-specific primer-30, whereas the reverse primer lacked the
11 nucleotide barcode/multiplex identifier (MID) sequence and had
adapter sequence B instead of A. The forward and reverse fusion
primers were 64 and 53 nucleotides long, respectively. Thirteen
fusion forward primers with MIDs differing by at least 3 nucleotides
in the 8 first positions were used in combination with the fusion
reverse primer. This strategy allowed amplicons made with different
forward fusion primers to be pooled and sequenced in one batch and
data to be separated according to MID.
PCR was performed with TaKaRa LA Taq polymerase (TAKARA
Bio, Inc.) in 50 ll reactions mixed according to the manufacturer’s
recommendations (final primer concentrations: 1 lM) and the
following PCR program: 96°C for 45 s followed by 30 cycles of 96°C
for 10 s, 50°C for 20 s and 68°C for 20 s, and a final elongation at
72°C for 2 min.
DBLa-tag amplicon sequencing and analysis
Amplicons were purified by gel electrophoresis and subsequent
DNA extraction (E.Z.N.A. Gel Extraction Kit, Omega-Biotek). The
amplicons were sequenced unidirectionally (from adapter A) on a
GS FLX system with Titanium Lib-L chemistry. Sequence reads were
split according to their barcodes (allowing 1 mismatch and 0 dele-
tions) and trimmed from the 30 end until the minimum phred quality
score was ≥ 15 (evaluated in a window of 5 and a step size of 1).
Then, all reads with a median phred quality score < 20 or a read
length < 250 nucleotides were discarded. These procedures were
performed in a workflow designed on the Galaxy server http://
usegalaxy.org/ (Goecks et al, 2010).
Clustering of the reads from each patient was performed by
USEARCH version 5.0.144 (Edgar, 2010) (command line parameters:
–uclust –id 0.9 –gapopen 1 –gapext 1 –iddef 0 –maxrejects 128 –
nofastalign). An “R” script (http://www.r-project.org/) was written
to parse the clustering results (the “R” packages “ShortRead”
(Morgan et al, 2009), and “Biostrings” were used to handle the
reads). In order to clean out singletons and other rare sequences
prone to be PCR or sequencing artefacts, clusters containing < 1%
of the total reads were discarded from the expression profile analy-
sis. On average 14.3  6.8% of the clustered reads were discarded
on that account. Consensus sequences were determined from multi-
ple alignments generated by MUSCLE (Edgar, 2004) manually edited
in BioEdit version 7.0.9.0. Profiles of var transcripts were generated
for each patient from the DBLa-tag results, with each read cluster
corresponding to a unique transcript and cluster size to the relative
transcript proportion originating from this gene.
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PCR amplification and amplicon sequencing of var exon 1
For each DBLa-tag sequence of interest, a tag-specific forward
primer was designed using Primer-BLAST preferably positioned
more than 100 nucleotides from the 30 end of the tag. These were
used in long-range PCRs in combination with a reverse primer
universal to exon 2 described in Lavstsen et al (2012). Amplicons
were separated by gel electrophoresis, and products of the expected
size (~5–12 kb) were excised and purified (E.Z.N.A. Gel Extraction
Kit, Omega-Biotek). The DNA concentration was measured by a
NanoDrop 2000 spectrophotometer (Thermo Scientific), and ampli-
cons were pooled in batches of 10–50 in equimolar proportions. The
batches were fragmentized by sonication (Bioruptor, Diagenode
S.A.) and built into MID labelled sequencing libraries. Sequencing
was performed with the Illumina HiSeq2000 system (100-bp single-
and paired-end) or MiSeq (250-bp paired-end).
Assembly and annotation of sequence data
The sequence data were assembled with Velvet version 1.2.03,
SPAdes version 2.5.1 or RAY version 2.2.0. Data were trimmed and
quality-filtered on the Galaxy server and error corrected with
ALLPATHS-LG (Gnerre et al, 2011) prior to assembly. Assemblies
were run with optimized k-mer sizes in the range 81–95 (Velvet) or
with multiple automatically selected k-mer sizes (SPAdes). The
target genes were identified among assembled contigs by BLAST
searching the contigs against a library of all the DBLa-tag sequences
targeted by long-range PCR. Every contig found to match a DBLa-
tag was then checked for the annealing sequence of the tag-specific
forward primer used in the long-range PCR. If the overlapping
sequence of tag and contig was < 98% identical or < 100 bp and did
not contain the primer sequence, the contig was considered an
invalid match.
Annotation of var encoded PfEMP1 domains was performed with
BLAST by gapped BLASTp searches (BLOSUM62 scoring matrix) in a
library of 2,476 annotated var domains from 395 var genes (Rask et al,
2010). One DC8 transcript (Appendix Fig S1, 1702-1) had a rare poly-
morphism at the key EPCR-interacting residue of the CIDRa1 (vali-
dated by PCR and Sanger sequencing), which changed the conserved
hydrophobic residue inserting into the hydrophobic groove of EPCR
(in other sequences phenylalanine (94%), tyrosine (2%) or valine
(3%)), to the negatively charged residue aspartic acid. This mutation
is predicted to cause markedly reduced affinity to EPCR (Lau et al,
2015) and the domain was considered to have an unknown binding
phenotype.
Validation of var gene assemblies and determination of relative
var transcript abundances
To validate that the assembled sequences were genuine, primer pairs
were designed along the sequence and intended to PCR amplify 2- to
3-kb regions of var genes from genomic DNA from each specific
patient. The PCR products were confirmed to have the expected size
by gel electrophoresis. The primer pairs were designed to amplify
regions overlapping by 50–300 bp, which also allowed using the
reverse and forward primers flanking an overlapping region as qPCR
primer pairs. Thus, 1–3 qPCR primer pairs were available for each
assembled transcript sequence. These were used in qPCR to validate
the transcript proportion reported by the DBLa-tag read count. qPCR
was performed on a Rotorgene thermal cycler system (Corbett
Research) with Quanti-Tect SYBR Green PCR Master Mix (Qiagen)
with primer concentrations of 2 lM and one primer pair for seryl-
tRNA synthetase as internal control as previously described (Lavstsen
et al, 2012). Transcript levels relative to the internal control gene
were calculated using the 2DCt method (Livak & Schmittgen, 2001).
Data analysis and statistics
The six most abundant var transcripts in each patient were first
identified from the distribution of unique DBLa-tag sequences. The
relative distribution of transcripts between the top six genes (tran-
script proportions) was used for the comparison of expression of
specific domains or domain combinations between patient groups.
For the statistical analysis and figures presented, DBLa-tag deter-
mined transcript proportions were adjusted according to the tran-
script abundances reported by the qPCR analysis of annotated
transcripts. Specifically, transcript proportions were calculated as
(2DCt gene#1)/Σ(2DCt (gene# 1–6) X(100  DBLa-tag determined tran-
script proportion (in per cent) of the un-annotated top six transcripts
within the patient), and proportions of top six un-annotated tran-
scripts were reported as determined by the DBLa-tag analysis, normal-
ized to the total proportion of top six transcripts. The data were also
analysed based on transcript abundance reported by the DBLa-tags
alone. The comparison between patient groups gave almost identical
results as those obtained by qPCR adjusted data. However, it should
be noted that the two methods of quantification produced slightly dif-
ferent results within a given patient. Comparison of the qPCR adjusted
and DBLa-tag profiles showed that a median of 21% transcript
proportion (IQR: 13–29%) was differently assigned with each profile
(range 5–67%). Also, a scatter plot comparing the results from the
two approaches validated subdominant and dominant transcripts
(Appendix Fig S2). The qPCR measured transcript abundances
(Appendix Fig S3) were also found to be on a par with var transcript
levels in placental malaria, involving only a single expressed var type,
var2csa (Tuikue Ndam et al, 2005).
A database stratified on patient identity was constructed in
Microsoft Excel and imported into Stata12, which was used for
statistical analyses. Difference in transcript levels between patient
groups was evaluated using Wilcoxon rank-sum tests.
Sequence data
The sequences generated in this study have been deposited in
GenBank under the following accession numbers: assembled genes
merged with DBLa tag: KX154815–KX154979 and DBLa tag
sequences alone: KX154980–KX155244. Sequences generated in a
previous study (Lavstsen et al, 2012) were also included in the anal-
ysis here. These are deposited under the GenBank accession
numbers JQ691636–JQ691650 (PopSet: 1024882945) and DBLa tags
JQ691651–JQ691659 (PopSet: 387175217).
Expanded View for this article is available online.
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The paper explained
Problem
More than half a million children die from malaria each year. Para-
sites causing life-threatening disease express a particularly virulent
subset of P. falciparum erythrocyte membrane protein 1 (PfEMP1)
molecules, mediating sequestration of infected erythrocytes in host
organs. The molecular characteristic of this PfEMP1 subset is impor-
tant for understanding severe malaria pathogenesis and development
of a vaccine.
Results
This study is the first to extract comprehensive sequence information
on PfEMP1-encoding genes expressed in children with severe malaria.
PfEMP1 with CIDRa1 domains, known to bind endothelial protein C
receptor (EPCR), were consistently found expressed in both children
suffering from severe malarial anaemia or cerebral malaria. No other
of the many PfEMP1 domain types identified was associated with
severe malaria symptoms. This points to the CIDRa1–EPCR interaction
being the key driver of severe malaria pathogenesis.
Impact
The identification of a single prominent PfEMP1 domain associated
with parasites from severe malaria patients is encouraging for the
prospects of elucidating the pathogenesis of malaria and developing a
PfEMP1-based vaccine or adjunctive treatment aiming at inhibiting or
reducing the burden of the disease.
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